Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces its pioneering efforts to develop ...

Smith & Nephew (NYSE:SNN) quickly edged higher by ~1% after a report that it's considering a break-up amid activist pressure.

Smith+Nephew submitted its TESSA System for FDA 510 (k) clearance, according to a March 4 news release. TESSA, which stands for Tracking Enabled Spatial Surgery Assistant, is pending FDA clearance for ...

Berenberg raised the firm’s price target on Smith & Nephew to 1,100 GBp from 1,050 GBp and keeps a Hold rating on the shares.Discover the ...

Smith+Nephew announced today that it aims to develop technology in a new field of arthroscopic surgical innovation.

Despite ongoing pressures in China, revenue and trading profit at the FTSE 100 firm rose 5.3% and 8.2% respectively in 2024.

Smith & Nephew Plc Chief Executive Officer Deepak Nath said a transformation plan unveiled two years ago will clearly start ...

Medical products maker Smith+Nephew's wound business will take a hit from U.S. tariffs on imports from China, as the British company has "significant" manufacturing in the Asian country for that ...

The medical-technology company was boosted by its sports medicine segment and an improved trading margin.

Smith+Nephew reported annual sales and profit broadly in line with expectations on Tuesday, as newer products and a recovery in the U.S., helped the medical products maker offset the impact of ...

The medical technology giant, which is listed on the FTSE 100, has been in the midst of a turnaround effort, and recently ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.